HomeCRBP • NASDAQ
add
Corbus Pharmaceuticals Holdings Inc
Previous close
$9.59
Year range
$4.64 - $20.56
Market cap
170.09M USD
Avg Volume
191.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.56M | -6.76% |
Net income | -20.56M | -115.69% |
Net profit margin | — | — |
Earnings per share | -1.25 | -60.26% |
EBITDA | -21.92M | -75.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 163.27M | 9.53% |
Total assets | 168.20M | 7.90% |
Total liabilities | 20.69M | 53.83% |
Total equity | 147.50M | — |
Shares outstanding | 17.74M | — |
Price to book | 1.14 | — |
Return on assets | -39.55% | — |
Return on capital | -45.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -20.56M | -115.69% |
Cash from operations | -15.92M | -45.50% |
Cash from investing | -57.14M | -754.58% |
Cash from financing | 74.58M | 573,753.85% |
Net change in cash | 1.51M | 167.82% |
Free cash flow | -8.61M | -3.16% |
About
Founded
Jan 1, 2009
Website
Employees
36
